Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...
Wedbush said Friday it expects North American box office to rise at least 7% in 2025, with double-digit growth in the second ...
"We see continued strong demand," Rubrik co-founder and CEO Bipul Sinha told me on Yahoo Finance on Friday. Sinha's comments ...
President Trump is locked in a tit-for-tat tariff war with Canada, Mexico, the European Union and China in a bid to remake ...
In-theater advertising company National CineMedia Inc. is well-positioned to reap the benefits of cinema’s unique proposition ...
Wedbush raised the firm’s price target on Rubrik (RBRK) to $80 from $75 and keeps an Outperform rating on the shares. The firm notes Rubrik ...
Wedbush analyst Richard Anderson maintained a Sell rating on CareTrust REIT (CTRE – Research Report) today and set a price target of $26.00.
Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at ...
It’s been a bad month for the stock market. But it’s been a terrible month—in fact, a terrible year—for Tesla. Even after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results